Media Database
>
Hannah Kuchler

Hannah Kuchler

Global Pharma Editor / Global Pharmaceuticals Correspondent at Financial Times

Contact this person
Email address
i*****@*******.comGet email address
Influence score
53
Phone
(XXX) XXX-XXXX Get mobile number
Location
United Kingdom
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

ft.com

Novo Nordisk partners with US biotech to boost pipeline of new obesity drugs

Potential ‘best-in-class’ medicine targets conditions that cost US health system billions a year
ft.com

Biotech billionaire Christian Angermayer: ‘Psychedelics can take aw...

The entrepreneur’s London penthouse is filled with bitcoin-inspired artworks, trippy sculptures and dinosaur skulls. Its an insight into his interest in exploring new frontiers
ft.com

Zealand Pharma says obesity drug deal with Roche will help it stay ...

Danish biotech is developing petrelintide in partnership with Swiss pharma group
ft.com

US patients lose access to cheaper weight-loss drugs as market for ...

Pharmacies told to stop making custom versions of Wegovy and Zepbound after shortages declared officially over
ft.com

Fund for struggling biotechs takes aim at ‘tragedy’ for shareholders

Alis Biosciences then plans to list and offer big investors an easy way to spread their bets
ft.com

Eli Lilly’s new obesity pill lowers blood sugar and aids weight loss

Promising late-stage trial results lift US pharmaceutical group’s shares almost 15%
ft.com

NHS signs deal with Scancell in ambitious skin cancer trial

Move comes as government seeks to boost UK’s standing as drugs research leader
ft.com

Swiss drugmaker Novartis to invest $23bn in US manufacturing and R&D

Pharma group builds out American supply chains as part of preparations for potential US tariffs
ft.com

UK promises rapid review of NHS drug-pricing rebate

Under the scheme, drugmakers discount price of medicines sold in bulk to healthcare system
ft.com

Former UK IPO star Nanopore admits it is a takeover target

DNA sequencing specialist’s decision to list in London in 2021 was seen as a victory for the market at the time
ft.com

Higher medicine sales tax makes UK ‘uninvestable’, warn drugmakers

Industry lobby group calls for action from government ahead of summit in April